Skip to content
Trial Eligibility
Menu

A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers

NCT07598136

This study is recruiting at 7 US sites in 6 states, according to its ClinicalTrials.gov record last updated .

Summary

The overall purpose of this study will be to assess primary combustible cigarette users' abstinence from smoking their usual brand of combustible cigarettes at the end of the study, when provided with an electronic nicotine delivery system (ENDS) power unit (2) and varying levels of access to tobacco-flavored, menthol-flavored, mint, or non-tobacco/non-menthol/non-mint-flavored cartridge-based e-liquids (collectively referred to as the investigational product) within their assigned study arm over a three-month (ninety-day) period.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Smoking
  • Tobacco

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
21 to 65 years
Sex
All
Healthy volunteers
Accepted
Sponsor
RAI Services Company
Last updated on ClinicalTrials.gov
June 3, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Florida · 1

  • Sago Orlando · Maitland, FL

Georgia · 1

  • Sago Atlanta · Atlanta, GA

Missouri · 1

  • Sago St. Louis · St Louis, MO

North Carolina · 1

  • L&E Raleigh · Raleigh, NC

Pennsylvania · 1

  • Sago Philadelphia · Philadelphia, PA

Texas · 2

  • Sago Dallas · Dallas, TX
  • Sago Houston · Houston, TX

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.